Overview – Bladder Cancer Clinical Trials Where We Stand At The End Of 2024
Daniel P. Petrylak, MD, analyzes bladder cancer treatment advancements, emphasizing recent clinical practice breakthroughs and challenges.
Read More
2024
Radiation Dose and Hormone Therapy: How Much is Enough?
Nelson N. Stone, MD, balances the radiation dose and hormonal therapy in managing intermediate- and high-risk prostate cancer.
Read More
Counterpoint: Radical Cystectomy for Muscle Invasive Bladder Cancer
Juan H. Chipollini, MD, FACS, provides an in-depth analysis of bladder-preserving approaches for muscle-invasive bladder cancer (MIBC).
Read More
Point: Bladder Sparing Approach for Muscle Invasive Bladder Cancer
Parminder Singh, MD, examines bladder preservation strategies for muscle-invasive bladder cancer (MIBC).
Read More
Diet and Prostate Cancer: What We Need to Know to Tell our Patients
Stacy Loeb, MD, MSc, PhD (hon), emphasizes integrating dietary and lifestyle modifications into prostate cancer management to improve patient outcomes. In this 21-minute presentation, Dr. Loeb notes that patients with localized disease are more likely to die from cardiovascular causes than prostate cancer itself, highlighting the opportunity to address broader health concerns.
Dr. Loeb introduces the six pillars of lifestyle medicine: whole food, plant-predominant nutrition, physical activity, restorative sleep, avoidance of toxic substances, social connection, and stress management. She emphasizes that plant-based diets, particularly whole foods, and plant-based patterns, reduce the risk of prostate cancer, cardiovascular disease, and erectile dysfunction while promoting environmental sustainability.
Loeb advocates for accessible patient resources, tailored educational materials, and collaboration among healthcare providers to promote these practices. The discussion addresses the importance of patient-centered approaches and the potential role of testosterone management in prostate cancer care.
Read More